Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Clinical trial NCT02953652 · COMPLETED
Trial details
- NCT number
- NCT02953652
- Sponsor
- HUYABIO International, LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2022-02-17
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.